세계의 망막 유리체 수술 기기 시장 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2031년)

Persistence Market Research has recently released a comprehensive report on the worldwide market for vitreoretinal surgery devices. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• Vitreoretinal Surgery Devices Market Size (2024E): USD 2241.3 million
• Projected Market Value (2031F): USD 3370 million
• Global Market Growth Rate (CAGR 2024 to 2031): 6.0%

Vitreoretinal Surgery Devices Market - Report Scope:

Vitreoretinal surgery devices play a crucial role in the treatment of various eye conditions, including retinal detachment, diabetic retinopathy, and macular degeneration. These devices encompass a range of tools such as vitrectomy machines, endoilluminators, and surgical instruments specifically designed for vitreoretinal procedures. The vitreoretinal surgery devices market caters to hospitals, outpatient surgical centers, and specialized ophthalmology clinics, providing advanced solutions to improve surgical outcomes and patient safety.

Market Growth Drivers:

The global vitreoretinal surgery devices market is propelled by several key factors, including the increasing prevalence of retinal disorders due to aging populations and rising incidences of diabetes-related eye diseases. The growing adoption of minimally invasive surgical techniques and advancements in device technology enhance surgical precision and recovery times, driving market expansion. Additionally, the rising healthcare expenditure and the increasing number of trained ophthalmic surgeons contribute to the market's positive outlook.

Market Restraints:

Despite promising growth prospects, the vitreoretinal surgery devices market faces challenges related to the high cost of advanced surgical equipment and the limited reimbursement policies in some regions. These factors can hinder access to necessary treatments, particularly in developing markets with constrained healthcare budgets. Furthermore, the complexity of vitreoretinal surgeries necessitates a high level of skill, which may restrict the number of qualified practitioners and limit market growth.

Market Opportunities:

The vitreoretinal surgery devices market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The integration of artificial intelligence and robotics in vitreoretinal surgery enhances precision and reduces the risk of complications. Additionally, the increasing focus on patient-centric care and telemedicine solutions allows for better preoperative assessments and postoperative follow-ups, creating new avenues for market players.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the vitreoretinal surgery devices market globally?
• Which device types and applications are driving vitreoretinal surgery adoption across different healthcare settings?
• How are technological advancements reshaping the competitive landscape of the vitreoretinal surgery devices market?
• Who are the key players contributing to the vitreoretinal surgery devices market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global vitreoretinal surgery devices market?

Competitive Intelligence and Business Strategy:

Leading players in the global vitreoretinal surgery devices market, including Alcon Inc., Bausch + Lomb, and Carl Zeiss AG, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced vitreoretinal solutions, including enhanced vitrectomy systems and imaging technologies, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers and academic institutions facilitate market access and promote technology adoption. Moreover, emphasis on clinical trials, regulatory compliance, and practitioner training fosters market growth and enhances patient outcomes in the rapidly evolving vitreoretinal surgery landscape.

Key Companies Profiled:

• Alcon Inc.
• Bausch + Lomb
• Carl Zeiss AG
• Abbott Medical Optics
• Haag-Streit AG
• Synergetics USA, Inc.
• DORC International
• Optos PLC
• Ellex Medical Lasers Limited
• MedOne Surgical

Vitreoretinal Surgery Devices Market Research Segmentation:

By Device Type:

• Vitrectomy Machines
• Endoilluminators
• Surgical Instruments
• Other Devices

By Application:

• Retinal Detachment Repair
• Diabetic Retinopathy Treatment
• Macular Degeneration Surgery
• Other Vitreoretinal Conditions

By End-User:

• Hospitals
• Outpatient Surgical Centers
• Ophthalmology Clinics
• Other Healthcare Facilities

By Region:

• North America
• Europe
• Asia Pacific
• Latin America

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation & Development Trends

4. Key Success Factors

• 4.1. Product USPs / Features
• 4.2. Key Promotional Strategies, By Manufacturers
• 4.3. Disease Epidemiology, By Key Regions
• 4.4. Regulatory Scenario

5. Global Vitreoretinal Surgery Devices Market - Pricing Analysis

• 5.1. Regional Pricing Analysis By Product Type
• 5.2. Pricing Break-up
  • 5.2.1. Distributor Level Pricing

6. Global Vitreoretinal Surgery Devices Market Demand (Value US$ Mn ) Analysis 2019-2023 and Forecast, 2024-2031

• 6.1. Historical Market Value (US$ Mn ) Analysis, 2019-2023
• 6.2. Current and Future Market Value (US$ Mn ) Projections, 2024-2031
  • 6.2.1. Y-o-Y Growth Trend Analysis
  • 6.2.2. Absolute $ Opportunity Analysis

7. Market Background

• 7.1. Macro-Economic Factors
  • 7.1.1. Global GDP Growth Outlook
  • 7.1.2. Global Healthcare Expenditure Outlook
• 7.2. Forecast Factors - Relevance & Impact
• 7.3. Value Chain
• 7.4. Market Dynamics
  • 7.4.1. Drivers
  • 7.4.2. Restraints
  • 7.4.3. Opportunity Analysis

8. Global Vitreoretinal Surgery Devices Market Analysis 2019-2023 and Forecast 2024-2031, by Product Type

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size (US$ Mn ) & Volume Analysis By Product Type, 2019-2023
• 8.3. Current and Future Market Size (US$ Mn ) & Volume Analysis and Forecast By Product Type, 2024-2031
  • 8.3.1. Vitrectomy Accessories
  • 8.3.2. Vitrectomy Packs
  • 8.3.3. Vitrectomy Machines
  • 8.3.4. Disposables
• 8.4. Market Attractiveness Analysis By Product Type

9. Global Vitreoretinal Surgery Devices Market Analysis 2019-2023 and Forecast 2024-2031, by Application

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Mn ) Analysis By Application, 2019-2023
• 9.3. Current and Future Market Size (US$ Mn ) Analysis and Forecast By Application, 2024-2031
  • 9.3.1. Diabetic Vitreous Hemorrhage
  • 9.3.2. Retinal Detachment
  • 9.3.3. Macular Hole
  • 9.3.4. Others
• 9.4. Market Attractiveness Analysis By Application

10. Global Vitreoretinal Surgery Devices Market Analysis 2019-2023 and Forecast 2024-2031, by End User

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn ) Analysis By End User, 2019-2023
• 10.3. Current and Future Market Size (US$ Mn ) Analysis and Forecast By End User, 2024-2031
  • 10.3.1. Hospitals
  • 10.3.2. Eye Clinics
  • 10.3.3. Ambulatory Surgical Centers
• 10.4. Market Attractiveness Analysis By End User

11. Global Vitreoretinal Surgery Devices Market Analysis 2019-2023 and Forecast 2024-2031, by Region

• 11.1. Introduction
• 11.2. Historical Market Size (US$ Mn ) Analysis By Region, 2019-2023
• 11.3. Current Market Size (US$ Mn ) Analysis and Forecast By Region, 2024-2031
  • 11.3.1. North America
  • 11.3.2. Latin America
  • 11.3.3. Europe
  • 11.3.4. South Asia
  • 11.3.5. East Asia
  • 11.3.6. Oceania
  • 11.3.7. Middle East & Africa (MEA)
• 11.4. Market Attractiveness Analysis By Region

12. North America Vitreoretinal Surgery Devices Market Analysis 2019-2023 and Forecast 2024-2031

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Mn ) & Volume Trend Analysis By Market Taxonomy, 2019-2023
• 12.3. Market Size (US$ Mn ) & Volume Forecast By Market Taxonomy, 2024-2031
  • 12.3.1. By Country
    • 12.3.1.1. U.S.
    • 12.3.1.2. Canada
  • 12.3.2. By Product Type
  • 12.3.3. By Application
  • 12.3.4. By End User
• 12.4. Market Attractiveness Analysis
  • 12.4.1. By Country
  • 12.4.2. By Product Type
  • 12.4.3. By Application
  • 12.4.4. By End User
• 12.5. Market Trends
• 12.6. Key Market Participants - Intensity Mapping
• 12.7. Drivers and Restraints - Impact Analysis

13. Latin America Vitreoretinal Surgery Devices Market Analysis 2019-2023 and Forecast 2024-2031

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn ) & Volume Trend Analysis By Market Taxonomy, 2019-2023
• 13.3. Market Size (US$ Mn ) & Volume Forecast By Market Taxonomy, 2024-2031
  • 13.3.1. By Country
    • 13.3.1.1. Brazil
    • 13.3.1.2. Mexico
    • 13.3.1.3. Rest of Latin America
  • 13.3.2. By Product Type
  • 13.3.3. By Application
  • 13.3.4. By End User
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Product Type
  • 13.4.3. By Application
  • 13.4.4. By End User
• 13.5. Market Trends
• 13.6. Key Market Participants - Intensity Mapping
• 13.7. Drivers and Restraints - Impact Analysis

14. Europe Vitreoretinal Surgery Devices Market Analysis 2019-2023 and Forecast 2024-2031

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn ) & Volume Trend Analysis By Market Taxonomy, 2019-2023
• 14.3. Market Size (US$ Mn ) & Volume Forecast By Market Taxonomy, 2024-2031
  • 14.3.1. By Country
    • 14.3.1.1. Germany
    • 14.3.1.2. Italy
    • 14.3.1.3. France
    • 14.3.1.4. U.K.
    • 14.3.1.5. Spain
    • 14.3.1.6. Russia
    • 14.3.1.7. BENELUX
    • 14.3.1.8. Rest of Europe
  • 14.3.2. By Product Type
  • 14.3.3. By Application
  • 14.3.4. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product Type
  • 14.4.3. By Application
  • 14.4.4. By End User
• 14.5. Market Trends
• 14.6. Key Market Participants - Intensity Mapping
• 14.7. Drivers and Restraints - Impact Analysis

15. South Asia Vitreoretinal Surgery Devices Market Analysis 2019-2023 and Forecast 2024-2031

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn ) & Volume Trend Analysis By Market Taxonomy, 2019-2023
• 15.3. Market Size (US$ Mn ) & Volume Forecast By Market Taxonomy, 2024-2031
  • 15.3.1. By Country
    • 15.3.1.1. India
    • 15.3.1.2. Thailand
    • 15.3.1.3. Indonesia
    • 15.3.1.4. Malaysia
    • 15.3.1.5. Rest of South Asia
  • 15.3.2. By Product Type
  • 15.3.3. By Application
  • 15.3.4. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product Type
  • 15.4.3. By Application
  • 15.4.4. By End User
• 15.5. Market Trends
• 15.6. Key Market Participants - Intensity Mapping
• 15.7. Drivers and Restraints - Impact Analysis

16. East Asia Vitreoretinal Surgery Devices Market Analysis 2019-2023 and Forecast 2024-2031

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn ) & Volume Trend Analysis By Market Taxonomy, 2019-2023
• 16.3. Market Size (US$ Mn ) & Volume Forecast By Market Taxonomy, 2024-2031
  • 16.3.1. By Country
    • 16.3.1.1. China
    • 16.3.1.2. Japan
    • 16.3.1.3. South Korea
  • 16.3.2. By Product Type
  • 16.3.3. By Application
  • 16.3.4. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product Type
  • 16.4.3. By Application
  • 16.4.4. By End User
• 16.5. Market Trends
• 16.6. Key Market Participants - Intensity Mapping
• 16.7. Drivers and Restraints - Impact Analysis

17. Oceania Vitreoretinal Surgery Devices Market Analysis 2019-2023 and Forecast 2024-2031

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn ) & Volume Trend Analysis By Market Taxonomy, 2019-2023
• 17.3. Market Size (US$ Mn ) & Volume Forecast By Market Taxonomy, 2024-2031
  • 17.3.1. By Country
    • 17.3.1.1. Australia
    • 17.3.1.2. New Zealand
  • 17.3.2. By Product Type
  • 17.3.3. By Application
  • 17.3.4. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product Type
  • 17.4.3. By Application
  • 17.4.4. By End User
• 17.5. Market Trends
• 17.6. Key Market Participants - Intensity Mapping
• 17.7. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Vitreoretinal Surgery Devices Market Analysis 2019-2023 and Forecast 2024-2031

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn ) & Volume Trend Analysis By Market Taxonomy, 2019-2023
• 18.3. Market Size (US$ Mn ) & Volume Forecast By Market Taxonomy, 2024-2031
  • 18.3.1. By Country
    • 18.3.1.1. GCC Countries
    • 18.3.1.2. South Africa
    • 18.3.1.3. Turkey
    • 18.3.1.4. Rest of Middle East and Africa
  • 18.3.2. By Product Type
  • 18.3.3. By Application
  • 18.3.4. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product Type
  • 18.4.3. By Application
  • 18.4.4. By End User
• 18.5. Market Trends
• 18.6. Key Market Participants - Intensity Mapping
• 18.7. Drivers and Restraints - Impact Analysis

19. Emerging Countries Vitreoretinal Surgery Devices Market Analysis 2019-2023 and Forecast 2024-2031

• 19.1. China Vitreoretinal Surgery Devices Market Analysis
  • 19.1.1. Introduction
  • 19.1.2. PEST Analysis
  • 19.1.3. Market Value Proportion Analysis by Market Taxonomy
  • 19.1.4. Market Value (US$ Mn ) & Volume Analysis and Forecast by Market Taxonomy
    • 19.1.4.1. By Product Type
    • 19.1.4.2. By Application
    • 19.1.4.3. By End User
  • 19.1.5. China Vitreoretinal Surgery Devices Market - Competition Landscape
• 19.2. India Vitreoretinal Surgery Devices Market Analysis
  • 19.2.1. Introduction
  • 19.2.2. Pricing Analysis
  • 19.2.3. Market Value Proportion & Volume Analysis by Market Taxonomy
  • 19.2.4. Market Value (US$ Mn ) Analysis and Forecast by Market Taxonomy
    • 19.2.4.1. By Product Type
    • 19.2.4.2. By Application
    • 19.2.4.3. By End User
  • 19.2.5. India Vitreoretinal Surgery Devices Market - Competition Landscape
• 19.3. South Korea Vitreoretinal Surgery Devices Market Analysis
  • 19.3.1. Introduction
  • 19.3.2. PEST Analysis
  • 19.3.3. Market Value Proportion & Volume Analysis by Market Taxonomy
  • 19.3.4. Market Value (US$ Mn ) Analysis and Forecast by Market Taxonomy
    • 19.3.4.1. By Product Type
    • 19.3.4.2. By Application
    • 19.3.4.3. By End User
  • 19.3.5. South Korea Vitreoretinal Surgery Devices Market - Competition Landscape

20. Market Structure Analysis

• 20.1. Market Analysis by Tier of Companies
• 20.2. Market Share Analysis of Top Players
• 20.3. Market Presence Analysis
  • 20.3.1. Product foot print by Players
  • 20.3.2. Channel Foot Print by Players

21. Competition Analysis

• 21.1. Competition Dashboard
• 21.2. Competition Benchmarking
• 21.3. Competition Deep Dive
  • 21.3.1. Alcon, Inc.
    • 21.3.1.1. Overview
    • 21.3.1.2. Product Portfolio
    • 21.3.1.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.1.4. Sales Footprint
    • 21.3.1.5. Strategy Overview
      • 21.3.1.5.1. Marketing Strategy
      • 21.3.1.5.2. Product Strategy
      • 21.3.1.5.3. Channel Strategy
  • 21.3.2. Dutch Ophthalmic Research Center International B.V.
    • 21.3.2.1. Overview
    • 21.3.2.2. Product Portfolio
    • 21.3.2.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.2.4. Sales Footprint
    • 21.3.2.5. Strategy Overview
      • 21.3.2.5.1. Marketing Strategy
      • 21.3.2.5.2. Product Strategy
      • 21.3.2.5.3. Channel Strategy
  • 21.3.3. Bausch & Lomb Incorporated
    • 21.3.3.1. Overview
    • 21.3.3.2. Product Portfolio
    • 21.3.3.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.3.4. Sales Footprint
    • 21.3.3.5. Strategy Overview
      • 21.3.3.5.1. Marketing Strategy
      • 21.3.3.5.2. Product Strategy
      • 21.3.3.5.3. Channel Strategy
  • 21.3.4. Geuder AG
    • 21.3.4.1. Overview
    • 21.3.4.2. Product Portfolio
    • 21.3.4.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.4.4. Sales Footprint
    • 21.3.1.5. Strategy Overview
      • 21.3.4.5.1. Marketing Strategy
      • 21.3.4.5.2. Product Strategy
      • 21.3.4.5.3. Channel Strategy
  • 21.3.5. Carl Zeiss
    • 21.3.5.1. Overview
    • 21.3.5.2. Product Portfolio
    • 21.3.5.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.5.4. Sales Footprint
    • 21.3.5.5. Strategy Overview
      • 21.3.5.5.1. Marketing Strategy
      • 21.3.5.5.2. Product Strategy
      • 21.3.5.5.3. Channel Strategy
  • 21.3.6. Hooya Corporation
    • 21.3.6.1. Overview
    • 21.3.6.2. Product Portfolio
    • 21.3.6.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.6.4. Sales Footprint
    • 21.3.6.5. Strategy Overview
      • 21.3.6.5.1. Marketing Strategy
      • 21.3.6.5.2. Product Strategy
      • 21.3.6.5.3. Channel Strategy
  • 21.3.7. Cooper vision
    • 21.3.7.1. Overview
    • 21.3.7.2. Product Portfolio
    • 21.3.7.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.7.4. Sales Footprint
    • 21.3.7.5. Strategy Overview
      • 21.3.7.5.1. Marketing Strategy
      • 21.3.7.5.2. Product Strategy
      • 21.3.7.5.3. Channel Strategy
  • 21.3.8. Ellex Medical Lasers
    • 21.3.8.1. Overview
    • 21.3.8.2. Product Portfolio
    • 21.3.8.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.8.4. Sales Footprint
    • 21.3.8.5. Strategy Overview
      • 21.3.8.5.1. Marketing Strategy
      • 21.3.8.5.2. Product Strategy
      • 21.3.8.5.3. Channel Strategy
  • 21.3.9. Safilo Group
    • 21.3.9.1. Overview
    • 21.3.9.2. Product Portfolio
    • 21.3.9.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.9.4. Sales Footprint
    • 21.3.9.5. Strategy Overview
      • 21.3.9.5.1. Marketing Strategy
      • 21.3.9.5.2. Product Strategy
      • 21.3.9.5.3. Channel Strategy
  • 21.3.10. Rodenstock
    • 21.3.10.1. Overview
    • 21.3.10.2. Product Portfolio
    • 21.3.10.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.10.4. Sales Footprint
    • 21.3.10.5. Strategy Overview
      • 21.3.10.5.1. Marketing Strategy
      • 21.3.10.5.2. Product Strategy
      • 21.3.10.5.3. Channel Strategy
  • 21.3.11. Erbe Elektromedizin
    • 21.3.11.1. Overview
    • 21.3.11.2. Product Portfolio
    • 21.3.11.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.11.4. Sales Footprint
    • 21.3.11.5. Strategy Overview
      • 21.3.11.5.1. Marketing Strategy
      • 21.3.11.5.2. Product Strategy
      • 21.3.11.5.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology